1. Home
  2. BFAM vs DNLI Comparison

BFAM vs DNLI Comparison

Compare BFAM & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Horizons Family Solutions Inc.

BFAM

Bright Horizons Family Solutions Inc.

HOLD

Current Price

$65.03

Market Cap

3.6B

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$21.36

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFAM
DNLI
Founded
1986
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.0B
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
BFAM
DNLI
Price
$65.03
$21.36
Analyst Decision
Buy
Strong Buy
Analyst Count
7
14
Target Price
$114.57
$34.33
AVG Volume (30 Days)
1.1M
1.7M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
40.00
N/A
EPS
0.62
N/A
Revenue
$1,903,182,000.00
N/A
Revenue This Year
$8.19
N/A
Revenue Next Year
$5.83
$408.85
P/E Ratio
$105.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$57.63
$12.58
52 Week High
$130.76
$23.77

Technical Indicators

Market Signals
Indicator
BFAM
DNLI
Relative Strength Index (RSI) 46.02 60.95
Support Level $64.34 $17.77
Resistance Level $104.97 $22.07
Average True Range (ATR) 2.78 1.05
MACD 0.79 0.17
Stochastic Oscillator 73.02 79.73

Price Performance

Historical Comparison
BFAM
DNLI

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; Full-service center-based child care, Backup care, and Educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: